Wipro founder and chairman Azim Premji is an early investor in US-based Moderna, which is working on an experimental Covid-19 vaccine
The investment happened via PremjiInvest, his private investment arm which manages billions of dollars in assets
Dhiraj Malkani, a partner at Premji Invest in Boston also recently shared news about their portfolio company Moderna on his LinkedIn page.
Sources claim that Premji Invest invested $25-30 million in the company a few years ago. Premji Invest has also placed its bets on other US-based healthtech companies such as Devoted Health, Iora Health and Grand Rounds.
Moderna is at the forefront of the COVID-19 vaccine race. The NASDAQ-listed company had recently announced positive data from the phase 1 of its vaccine testing in the United States
According to early results released by the company, Moderna's vaccine has produced protective antibodies in a small group of healthy volunteers.
